The US Department of Health and Human Services said Tuesday it awarded a  million contract to Mapp Biopharmaceutical Inc to fund the manufacture of a small amount of experimental Ebola treatment ZMapp and to speed the drugs development  The new supply to be funded with the month contract would be used in earlystage clinical studies to test the drugs safety and efficacy HHS said The contract can be expanded to a value of up to about  million HHS said